• Ouabain: From Pump Blockade to Vascular Assays

  2026-08-17

  Ouabain is a selective Na+/K+-ATPase inhibitor with powerful applications in ion-transport and cardiovascular research. This guide explains how to connect pump inhibition, calcium handling, and vascular assay design while avoiding common interpretation errors.

• S Tag Peptide (A6007): Practical Workflow Guide

  2026-08-17

  S Tag Peptide is a short, highly soluble RNase A-derived peptide used to support recombinant protein detection, solubility improvement, and antibody-based purification when encoded as a fusion tag. It is suitable for aqueous or DMSO workflows, but not for ethanol-based solubilization, long-term storage of solutions, or use as an independently active ribonuclease reagent.

• Actinomycin D for AML mRNA Stability Assays

  2026-08-16

  Actinomycin D turns transcriptional arrest into a practical way to measure EPOR mRNA decay, transcriptional stress, and treatment-linked apoptosis in AML models. This workflow combines dose-controlled ActD exposure with IGF2BP3 perturbation to distinguish mRNA stability effects from nonspecific cytotoxicity.

• Trolox in Pancreatic Ductal Organoid Research

  2026-08-15

  Trolox can do more than benchmark antioxidant capacity: it can help dissect redox-dependent variability in pancreatic ductal organoid workflows. This article connects its chemistry with organoid initiation, lineage fidelity, oxidative injury research, and assay design limitations.

• Berberrubine chloride Research Workflows

  2026-08-14

  Berberrubine chloride supports mechanism-led workflows spanning IMPDH2-dependent colorectal cancer research, NSCLC chemosensitivity, urate metabolism, and inflammatory signaling. This guide translates reported activity into practical assay design, dosing logic, controls, and troubleshooting steps for reproducible research use.

• Everolimus (RAD001) in Reliable Cell Assays

  2026-08-14

  This scenario-based guide explains how Everolimus (RAD001), SKU A8169, can support more interpretable mTOR inhibition, proliferation, and cytotoxicity experiments. It connects mechanism, solvent handling, endpoint selection, dose interpretation, and supplier-quality criteria to practical laboratory decisions.

• Whole-Blood circUSP10 for Early NSCLC Diagnosis

  2026-08-13

  The reference study identified hsa_circ_0003026, termed circUSP10, as an elevated circular RNA in early-stage non-small-cell lung cancer and evaluated its detectability in whole blood. Its paired tissue-screening and blood-based validation strategy supports circUSP10 as a candidate minimally invasive biomarker, while also highlighting the need for larger, independent clinical validation.

• Tacrine Hydrochloride Hydrate in Translational AD Research

  2026-08-13

  Tacrine hydrochloride hydrate, also known as Tetrahydroaminacrine, remains a valuable mechanistic tool for connecting cholinergic biology with translational Alzheimer’s disease research. This article outlines how to use its pharmacology responsibly, validate assay performance, interpret metabolism-related findings, and design safer next-generation strategies.

• AmpliFold Capture-and-Release for Sensitive LFAs

  2026-08-12

  The AmpliFold strategy addresses a central limitation of lateral flow assays: insufficient time for analyte complexes to associate efficiently at a narrow test line. By capturing HER2 sandwich complexes across a broad surface, chemically releasing them, and rebinding them at a concentrated detection line, the study achieved up to 16-fold sensitivity improvement while retaining a rapid, equipment-free workflow.

• WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis

  2026-08-12

  The 2020 Cell Death & Differentiation study identifies the WNT5a/GSK3/β-catenin axis as a regulatory checkpoint that restrains adipogenic differentiation of skeletal-muscle fibro/adipogenic progenitors. By combining pharmacological inhibition, mass cytometry, mouse injury models, and transcriptomic network analysis, the authors connect impaired WNT5a signaling with fatty degeneration and altered support for muscle regeneration.

• Amikacin Sulfate: Reliable Assay Workflows

  2026-08-11

  Learn how Amikacin Sulfate, SKU C8696, can improve the interpretation and reproducibility of antimicrobial, intracellular infection, and mammalian-cell compatibility experiments. This scenario-driven guide connects concentration selection, assay controls, storage, and vendor evaluation to published and product-dossier evidence.

• Sulfamonomethoxine Toxicity Across Five Aquatic Species

  2026-08-11

  Huang and colleagues evaluated the acute and chronic toxicity of the veterinary sulfonamide sulfamonomethoxine across algae, cladocerans, and medaka fish. The study shows that microalgae were more sensitive than cladocerans, while chronic reproductive effects in Daphnia occurred at lower concentrations than acute lethality, strengthening the case for trophic-level and endpoint-specific risk assessment.

• L-Alanyl-L-Glutamine for Barrier Workflows

  2026-08-10

  L-Alanyl-L-glutamine is a water-soluble, stable dipeptide for intestinal barrier, mucosal stress, and nutrient-support experiments where free glutamine handling can compromise reproducibility. This guide pairs practical dosing, assay controls, and storage advice with a cautious translation of a coronavirus drug-screening workflow—without implying antiviral activity for the dipeptide.

• Kitasamycin for Swine Dysentery: Evidence from Pigs

  2026-08-09

  The reference study combined susceptibility testing, 23S rRNA mutation analysis, and a controlled pig challenge to evaluate kitasamycin against Brachyspira hyodysenteriae. Its findings support prophylactic and therapeutic activity against susceptible strains, while also showing why isolate-specific MIC testing and resistance surveillance are essential.

• Neuritin, ER Stress, and SAH Brain Injury

  2026-08-08

  The reference study connects endoplasmic reticulum stress to neuroinflammation and neuronal apoptosis during early brain injury after subarachnoid hemorrhage. Its central contribution is showing that neuritin overexpression suppresses three ER stress-associated NF-κB signaling routes, providing a mechanistic framework for interpreting neuroprotective interventions.

16780 records 1/1119 page Next 12345 下5页 Last page